购物车
0
有库存
HIT220912903
 sdf 文件
结构编辑
类似物检索
HIT220912903
  • HIT ID:HIT220912903
  • Cas No:135447-13-1
  • 常用名:Avidinorubicin
  • IUPAC:4-{[6-({4-amino-6-[(4-amino-6-{[23-(dimethylamino)-10-{[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8,12,15,22-tetrahydroxy-1,12-dimethyl-6,17-dioxo-20,25-dioxahexacyclo[19.3.1.0^{2,19}.0^{5,18}.0^{7,16}.0^{9,14}]pentacosa-2,4,7(16),8,14,18-hexaen-24-yl]oxy}-2,4-dimethyloxan-3-yl)oxy]-2,4-dimethyloxan-3-yl}oxy)-4-methoxy-2-methyloxan-3-yl]oxy}-4-oxobutanoic acid
    IUPAC:4-{[6-({4-amino-6-[(4-amino-6-{[23-(dimethylamino)-10-{[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8,12,15,22-tetrahydroxy-1,12-dimethyl-6,17-dioxo-20,25-dioxahexacyclo[19.3.1.0^{2,19}.0^{5,18}.0^{7,16}.0^{9,14}]pentacosa-2,4,7(16),8,14,18-hexaen-24-yl]oxy}-2,4-dimethyloxan-3-yl)oxy]-2,4-dimethyloxan-3-yl}oxy)-4-methoxy-2-methyloxan-3-yl]oxy}-4-oxobutanoic acid
  • InChI key:InChIKey=XMRHMVSZMLOUMS-UHFFFAOYSA-N
  • 分子式:C60H86N4O22
  • 分子量:1215.354
  • 氢键供体数 (HBD):
  • 氢键受体数 (HBA):
  • LogP:
  • SMILES:COC1CC(OC2C(C)OC(CC2(C)N)OC2C(C)OC(CC2(C)N)OC2C(C(O)C3Oc4c(ccc5C(=O)c6c(O)c7C(CC(C)(O)Cc7c(O)c6C(=O)c45)OC4CC(C(O)C(C)O4)N(C)C)C2(C)O3)N(C)C)OC(C)C1OC(=O)CCC(O)=O
    SMILES:COC1CC(OC2C(C)OC(CC2(C)N)OC2C(C)OC(CC2(C)N)OC2C(C(O)C3Oc4c(ccc5C(=O)c6c(O)c7C(CC(C)(O)Cc7c(O)c6C(=O)c45)OC4CC(C(O)C(C)O4)N(C)C)C2(C)O3)N(C)C)OC(C)C1OC(=O)CCC(O)=O
  • Avidinorubicin is a novel anthracycline with platelet aggregation inhibitory activity.
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    6-8周
    纯度
    -
    ¥ 10,600.00
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~